Current:
- Florida Breast Cancer Foundation. Copik (PI) 07/2024 – 06/2025 Project Number: SGA1276057 “Natural Killer Cell-Based Strategies for the Treatment of Breast Cancer”
- NIH P01 P01AI179409 (PI/PDs: Bullita JB. and Drusano JL UF, Copik, A (Co-I)) “Translational development of new agents alone and in combination to combat Gram-negative pathogens important in Ventilator- Associated Bacterial Pneumonia: Leveraging the Gram-negative toolbox that is ready for prime time”
Completed:
- Live Like Bella Pediatric Cancer Research Program. Copik (PI) 2022 – 2025 FL DOH Grant#22L04 Edited “Natural Killer cells as an immunotherapeutic approach for the treatment of pediatric cancers”
- Live Like Bella Pediatric Cancer Research Program. PI: Parks GD, Copik, AJ (Co-PI) 2022 – 2025 FL DOH Grant#22L05 “Oncolytic virus in combination with NK cells for treatment of pediatric cancers”
- James and Ester King Biomedical Research Program: Copik (PI) 2019 – 2022 FL DOH Grant#9JK04 “Adoptive PM21-NK cells with PD-L1 blockade for treatment of lung cancer”
- American Lung Association: PI: Parks GD, Copik, AJ (Co-PI) 07/2019 – 06/2020 ALA Grant#LCD-619391 “Novel Oncolytic Virus for Redirecting NK Cell Killing of Lung Cancer Cells”
- Kiadis Pharma, a Sanofi Company Copik, A (PI) 2022 – 2024 Research Collaboration
- Kiadis Pharma Copik, A (PI) 11/01/2019 – 12/31/2021 Research Collaboration
- NIH 1R01AI136803-01 (PI: Jurgen Bullita UF, Alicja Copik (Co-I))
- Guillot-Henley Family AML Research Fund in loving memory of William L. Guillot Copik (PI) 2017 – 2020
- Cyto-Sen Therapeutics, Inc. Copik, A (PI) 10/01/2018 – 12/15/2019 Research Collaboration – TO3
- Cyto-Sen Therapeutics, Inc. Copik, A (PI) 06/01/2018 – 09/30/2018 Research Collaboration – TO2
- Cyto-Sen Therapeutics, Inc. Copik, A (PI) 11/01/2017 – 05/31/2018 Research Collaboration – TO1
- Cyto-Sen Therapeutics, Inc. Copik, A (PI) 10/01/2016 – 07/30/2017 Research Collaboration
- Breast Cancer Research Foundation Khaled, A(PI), Copik (Co-PI) 03/01/2017 – 02/29/2018 0769010006 “Development of a Cytoskeletal- Disrupting Approach for the Treatment of Metastic Breast Cancer”
- UCF College of Medicine (COM) Copik, A (PI) 01/01/2016 – 11/30/2016 “Harnessing the power of NK cells and oncolytic viruses for novel treatment of ovarian cancer.”
- UCF College of Medicine (COM) Copik, A (PI) 01/01/2016 – 11/30/2016 “Toward development of NK cell therapy for HIV treatment.”
- Bankhead-Coley Biomedical Research Program: Copik (PI) 12/01/2013 – 12/01/2015 Grant#4BB06 “Establishing Particle-Activated Natural Killer cell therapy for treatment of AML in preclinical NSG mouse model”
- NIR Bankhead-Coley Biomedical Research Program: Copik (PI) 07/01/2012 – 12/31/2015 Grant#3BN02 “Generation of highly cytotoxic natural killer cells for cancer immunotherapy using novel microparticle approach”
- UCF College of Medicine (COM): Copik, A (PI) 11/1/2014 – 10/30/2015 Grant#A_2014_016 “Determining the mechanism(s) of plasma membrane particle stimulated natural killer cell expansion.”
- The Florida Hospital Gala Endowed Program for Oncology Research: Copik (PI) 2011 – 2013 “Developing Strategies for Immunotherapy using Natural Killer Cells”
For more information regarding donations, please see the following link: